Olumodeji Ayokunle Moses, Okere Raymond Akujuobi, Adebara Idowu Oluwaseyi, Ajani Gbadebo Oladimeji, Adewara Olumide Emmanuel, Ghazali Segun Murtala, Olumodeji Ufuoma Oluwaseyi
Institute of Maternal and Child Health, Lagos State University Teaching Hospital, Lagos, Nigeria.
Department of Obstetrics and Gynaecology, Federal Teaching Hospital, Ido-Ekiti, Ekiti State, Nigeria.
Pan Afr Med J. 2020 Jul 22;36:208. doi: 10.11604/pamj.2020.36.208.20818. eCollection 2020.
the World Health Organization (WHO) reviewed the threshold values required for the diagnosis of Gestational Diabetes Mellitus (GDM) in 2013 and the implementation of the new diagnostic criteria have been associated with increase in the prevalence of GDM in some populations. The new cohort of pregnant women that will be labeled to have GDM by the 2013 WHO diagnostic criteria but not by the 1999 WHO diagnostic criteria will pose additional burden to specialized antenatal care, though their pregnancy outcome may not warrant such care. It is thus important to first determine the effect of the implementation of these new consensus diagnostic criteria on the prevalence of GDM in our environment.
this is a prospective hospital-based study that compared the implementation of both 1999 and 2013 WHO GDM diagnostic criteria among 117 pregnant women who were initially screened with 50-gram Glucose Challenge Test (50-g GCT). Women with a positive Glucose Challenge Test (GCT) result underwent a 75-gram Oral Glucose Tolerance Test (75-g OGTT), which was used as the actual diagnostic test for GDM using both 2013 WHO and 1999 WHO diagnostic criteria. Associations between variables were tested using Chi-square, Fisher's exact and t-test as appropriate. Significance level was set at P value < 0.05.
the prevalence rates of GDM in the study were 2.6% and 7.7% for 1999 WHO and 2013 WHO criteria respectively. Clinical characteristics were similar in women with GDM and women without GDM. The fasting component of the OGTT identified all the women with GDM.
the implementation of the 2013 WHO diagnostic criteria is associated with a 2.5 to 3-fold rise in the prevalence of GDM. Selective risk-factor based screening may be clinically irrelevant with the adoption of the 2013 WHO diagnostic criteria. A minimum of fasting plasma glucose in resource poor settings can be considered to identify women with GDM since it appeared to have 100% sensitivity in our study.
世界卫生组织(WHO)在2013年对妊娠期糖尿病(GDM)诊断所需的阈值进行了审查,新诊断标准的实施与某些人群中GDM患病率的增加有关。按照2013年WHO诊断标准会被判定为患有GDM,但按照1999年WHO诊断标准则不会的这一新一批孕妇,将给专科产前护理带来额外负担,尽管她们的妊娠结局可能并不需要这种护理。因此,首先确定这些新的共识诊断标准的实施对我们所处环境中GDM患病率的影响很重要。
这是一项基于医院的前瞻性研究,比较了117名最初通过50克葡萄糖耐量试验(50-g GCT)进行筛查的孕妇中1999年和2013年WHO GDM诊断标准的实施情况。葡萄糖耐量试验(GCT)结果呈阳性的女性接受了75克口服葡萄糖耐量试验(75-g OGTT),该试验被用作按照2013年WHO和1999年WHO诊断标准诊断GDM的实际检测方法。变量之间的关联在适当情况下使用卡方检验、费舍尔精确检验和t检验进行检测。显著性水平设定为P值<0.05。
按照1999年WHO和2013年WHO标准,该研究中GDM的患病率分别为2.6%和7.7%。患有GDM的女性和未患GDM的女性的临床特征相似。OGTT的空腹部分识别出了所有患有GDM的女性。
2013年WHO诊断标准的实施与GDM患病率上升2.5至3倍有关。采用2013年WHO诊断标准后,基于选择性风险因素的筛查在临床上可能并无关联。在资源匮乏地区,由于空腹血糖在我们的研究中似乎具有100%的敏感性,因此可以考虑将其作为识别患有GDM女性的最低标准。